InsidersTradesSigma
Explore the complete record of transactions filed by Bent Frandsen, Chief Executive Officer. Officer active across 2 companies, notably Expres2ion Biotech Holding AB. In total, 2 filings have been published. History available since 20 April 2026. The latest transaction was filed on 1 May 2026 (Purchase). Regulator: FIN-FSA. All data is openly available.
2 of 2 declarations
Bent Frandsen is the Chief Executive Officer of Expres2ion Biotech Holding AB. He is responsible for the daily management of the company and the implementation of its strategy. His leadership is essential for the development and growth of the company in the biotechnology sector.